B

Brain+ A/S
CSE:BRAINP

Watchlist Manager
Brain+ A/S
CSE:BRAINP
Watchlist
Price: 0.0098 DKK -2% Market Closed
Market Cap: 11.1m DKK

EV/EBITDA
Enterprise Value to EBITDA

-1.4
Current
-24.9
Median
12
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-1.4
=
Enterprise Value
11m DKK
/
EBITDA
-8.1m DKK
All Countries
Close
EBITDA Growth EV/EBITDA to Growth
DK
B
Brain+ A/S
CSE:BRAINP
Average EV/EBITDA: 42.4
Negative Multiple: -1.4
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
32.1
39%
0.8
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
136.2
32%
4.3
JP
M3 Inc
TSE:2413
16
14%
1.1
US
Doximity Inc
NYSE:DOCS
28.4
23%
1.2
US
W
Waystar Holding Corp
NASDAQ:WAY
17.1
24%
0.7
SE
Sectra AB
STO:SECT B
Negative Multiple: -116.9 N/A N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
37.2
24%
1.6
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -130.4
36%
N/A
US
Inspire Medical Systems Inc
NYSE:INSP
50.3
80%
0.6

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
N/A
2-Years Forward
EV/EBITDA
N/A
3-Years Forward
EV/EBITDA
N/A